Changes in incidence of diabetes mellitus-related eye disease among US elderly persons, 1994-2005

Archives of Ophthalmology

Volumn 126, Issue 11, 2008, Pages 1548-1553

  Sloan, Frank A ^a,b   Belsky, Daniel ^a   Ruiz Jr , David ^a   Lee, Paul ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNITED STATES;

AGED; BLOOD GLUCOSE; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; INSURANCE CLAIM REVIEW; LIPIDS; LONGITUDINAL STUDIES; MALE; MEDICARE PART B; UNITED STATES;

EID: 55949129763     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.126.11.1548     Document Type: Article

References (32)

1. Klein R. Has the frequency of proliferative diabetic retinopathy declined in the U.S.? Diabetes Care. 2003;26(9):2691-2692.
2. Sloan FA, Bethel MA, Ruiz D, et al. The growing burden of diabetes mellitus in the US elderly population [published correction appears in Arch Intern Med. 2008;168(8):860]. Arch Intern Med. 2008;168(2):192-199.
3. Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension. 1992; 19(5):403-418.
4. Klein R, Klein BEK. Relation of glycemic control to diabetic complications and health outcomes. Diabetes Care. 1998;21(suppl 3):C39-C43.
5. Lewis EJ, Hunsicker LG, Bain RP, et al. The effect of angiotensin-converting enzyme-inhibition on diabetic nephropathy. N Engl J Med. 1993;329(20):1456-1462.
6. Parving HH. Impact of blood-pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes-mellitus. Diabetes Care. 1991;14(3):260-269.
7. Snow V, Weiss KB, Mottur-Pilson C. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Ann Intern Med. 2003; 138(7):587-592.
8. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131): 837-853.
9. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703-713.
10. Diabetes Control and Complications Trial Study Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995;44(8):968-983.
11. Estacio RO, Gifford N, Jefers BW, Schrier R. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care. 2000;23(suppl 2):B54-B64.
12. Kohner EM, Aldington SJ, Stratton IM, et al. Diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol. 1998;116(3):297-303.
13. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type 2 diabetes over 6 years from diagnosis. Diabetologia. 2001;44(2):156-163.
14. Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM; UK Prospective Diabetes Study Group. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus, UKPDS 69. Arch Ophthalmol. 2004;122(11):1631-1640.
15. Kempen JH, O'Colmain BJ, Leske MC, et al; Eye Disease Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552-563.
16. Sloan FA, Bethel MA, Lee PP, Brown DS, Feingloss MN. Adherence to guidelines and its effects on hospitalizations with complications of type 2 diabetes. Rev Diabet Stud. 2004;1(1):29-38.
17. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
18. Lance LL, Lacy CH, Goldman MP, Armstrong LL, eds. Quick Look Drug Book. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
19. McClellan WM, Millman L, Presley R, Couzins J, Flander WD. Improved diabetes care by primary care physicians: results of a group-randomized evaluation of the Medicare Health Care Quality Improvement Program (HCQIP). J Clin Epidemiol. 2003;56(12):1210-1217.
20. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635-2645.
21. Peters AL, Legorreta AP, Ossorio RC, et al. Quality of outpatient care provided to diabetic patients: a health maintenance organization experience. Diabetes Care. 1996;19(6):601-606.
22. Brown JB, Pedula KL, Summer KH. Diabetic retinopathy: contemporary prevalence in a well-controlled population. Diabetes Care. 2003;26(9):2637-2642.
23. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, III: prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102(4):527-532.
24. Barr AG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med. 2002;137:E263-E272.
25. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20(12):1859-1862.
26. Dinneen SF, Maldonado D, Leibson CL, et al. Effects of changing diagnostic criteria in the risk of developing diabetes. Diabetes Care. 1998;21(9):1408-1413.
27. Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn P, McBean AM. Identifying persons with diabetes using Medicare claims data. Am J Med Qual. 1999; 14(6):270-277.
28. Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med. 2007;24(2):137-144.
29. Kell SH, Drass J, Bausell R, Thomas KA, Osborn MA, Cohdes D. Measures of disease control in Medicare beneficiaries with diabetes mellitus. J Am Geriatr Soc. 1999;47(4):417-422.
30. Saaddine JB, Engelau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KMV. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002;136(8):565-574.
31. Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology. 2003;110(10):1952-1959.
32. Morgan RO, Virnig BA, DeVito CA, Persily NA. The Medicare-HMO revolving door: the healthy go in and the sick go out. N Engl J Med. 1997;337(3):169-175.